Cardiogenic Shock Centers and Protocols for Acute Cardiovascular Care: Bridging the Gap Between Spoke and Hub Sites

Chirag Mehta1,2, Sahas Chandragiri3, Carl Atallah4

  • 1Department of Cardiology, Westchester Medical Center, New York Medical College, Valhalla, NY, USA.

Insights

Cardiogenic shock (CS) care can be improved at spoke sites with a generalizable approach. This review offers an algorithm for intrahospital escalation and stabilization strategies, regardless of multidisciplinary teams.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Health Systems Research

Background:

  • Cardiogenic shock (CS) presents significant inpatient morbidity and mortality.
  • The hub-and-spoke model promotes early transfer to specialized centers.
  • Current protocols are resource-intensive, limiting applicability at spoke sites and causing care inequities.

Purpose of the Study:

  • To provide a generalizable blueprint for cardiogenic shock management.
  • To develop an algorithm for intrahospital care escalation based on CS severity.
  • To offer stabilization and monitoring strategies independent of multidisciplinary teams.

Main Methods:

  • Literature review focusing on existing CS management protocols.
  • Development of a tiered algorithm for intrahospital care escalation.
  • Outline of essential stabilization and monitoring techniques for spoke sites.

Main Results:

  • A framework for a resource-independent CS management approach is proposed.
  • An algorithm stratifies care escalation based on patient acuity.
  • Practical stabilization and monitoring strategies are detailed for non-hub settings.

Conclusions:

  • A standardized, adaptable approach can improve cardiogenic shock outcomes at spoke sites.
  • Intrahospital escalation and monitoring protocols enhance care equity.
  • This review provides a practical guide for resource-limited settings.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...